{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:15:29Z","timestamp":1719069329734},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00108-018-0529-8","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T10:18:02Z","timestamp":1544437082000},"page":"3-9","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathogenese des Multiplen Myeloms"],"prefix":"10.1007","volume":"60","author":[{"given":"L.","family":"Rasche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"issue":"6","key":"529_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jamaoncol.2018.0509","volume":"4","author":"O Landgren","year":"2018","unstructured":"Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Thoren K et al (2018) Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster. JAMA Oncol 4(6):821\u2013827","journal-title":"JAMA Oncol."},{"issue":"3","key":"529_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1634\/theoncologist.2007-0242","volume":"13","author":"K Hemminki","year":"2008","unstructured":"Hemminki K, Sundquist J, Lorenzo Bermejo J (2008) Familial risks for cancer as the basis for evidence-based clinical referral and counseling. Oncologist 13(3):239\u2013247","journal-title":"Oncologist"},{"issue":"1","key":"529_CR3","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1038\/s41467-018-04989-w","volume":"9","author":"M Went","year":"2018","unstructured":"Went M, Sud A, Forsti A, Halvarsson BM, Weinhold N, Kimber S et\u00a0al (2018) Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nat Commun 9(1):3707\u20133713","journal-title":"Nat Commun"},{"issue":"10","key":"529_CR4","first-page":"619","volume":"1","author":"BM Halvarsson","year":"2017","unstructured":"Halvarsson BM, Wihlborg AK, Ali M, Lemonakis K, Johnsson E, Niroula A et\u00a0al (2017) Direct evidence for a\u00a0polygenic etiology in familial multiple myeloma. Blood 1(10):619\u2013623","journal-title":"Blood"},{"issue":"3","key":"529_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","volume":"107","author":"O Landgren","year":"2006","unstructured":"Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D et\u00a0al (2006) Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 107(3):904\u2013906","journal-title":"Blood"},{"issue":"6","key":"529_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa1508808","volume":"374","author":"S Nair","year":"2016","unstructured":"Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar MV (2016) Clonal immunoglobulin against lysolipids in the origin of myeloma. N\u00a0Engl J Med 374(6):555\u2013561","journal-title":"N Engl J Med"},{"key":"529_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95367","author":"A Bosseboeuf","year":"2017","unstructured":"Bosseboeuf A, Feron D, Tallet A, Rossi C, Charlier C, Garderet L et\u00a0al (2017) Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens. JCI Insight. \n                    https:\/\/doi.org\/10.1172\/jci.insight.95367","journal-title":"JCI Insight"},{"issue":"2","key":"529_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1055-9965.EPI-13-0695","volume":"23","author":"CM McShane","year":"2014","unstructured":"McShane CM, Murray LJ, Landgren O, O\u2019Rorke MA, Korde N, Kunzmann AT et\u00a0al (2014) Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a\u00a0systematic review. Cancer Epidemiol Biomarkers Prev 23(2):332\u2013342","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"529_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/17474086.2018.1489718","volume":"11","author":"GJ Morgan","year":"2018","unstructured":"Morgan GJ, Rasche L (2018) Maintaining therapeutic progress in multiple myeloma by integrating genetic and biological advances into the clinic. Expert Rev Hematol 11(7):513\u2013523","journal-title":"Expert Rev Hematol"},{"issue":"10","key":"529_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri1886","volume":"6","author":"A Radbruch","year":"2006","unstructured":"Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T et al (2006) Competence and competition: the challenge of becoming a\u00a0long-lived plasma cell. Nat Rev Immunol 6(10):741\u2013750","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"529_CR11","first-page":"323","volume":"69","author":"M Ichimaru","year":"1982","unstructured":"Ichimaru M, Ishimaru T, Mikami M, Matsunaga M (1982) Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950\u201376: relationship to radiation dose absorbed by marrow. J\u00a0Natl Cancer Inst 69(2):323\u2013328","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"529_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/leu.2013.199","volume":"28","author":"BA Walker","year":"2014","unstructured":"Walker BA, Wardell CP, Melchor L, Brioli A, Johnson DC, Kaiser MF et\u00a0al (2014) Intraclonal heterogeneity is a\u00a0critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia 28(2):384\u2013390","journal-title":"Leukemia"},{"issue":"6","key":"529_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3324\/haematol.2011.054015","volume":"97","author":"SY Kristinsson","year":"2012","unstructured":"Kristinsson SY, Tang M, Pfeiffer RM, Bjorkholm M, Goldin LR, Blimark C et al (2012) Monoclonal gammopathy of undetermined significance and risk of infections: a\u00a0population-based study. Haematologica 97(6):854\u2013858","journal-title":"Haematologica"},{"key":"529_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0206-x","author":"AK Dutta","year":"2018","unstructured":"Dutta AK, Fink JL, Grady JP, Morgan GJ, Mullighan CG, To LB et\u00a0al (2018) Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability. Leukemia. \n                    https:\/\/doi.org\/10.1038\/s41375-018-0206-x","journal-title":"Leukemia"},{"issue":"1","key":"529_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","volume":"8","author":"L Rasche","year":"2017","unstructured":"Rasche L, Chavan SS, Stephens OW, Patel PH, Tytarenko R, Ashby C et al (2017) Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun 8(1):268\u2013216","journal-title":"Nat Commun"},{"issue":"1","key":"529_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood-2018-04-842880","volume":"132","author":"L Rasche","year":"2018","unstructured":"Rasche L, Angtuaco EJ, Alpe TL, Gershner GH, McDonald JE, Samant RS et\u00a0al (2018) The presence of large focal lesions is a\u00a0strong independent prognostic factor in multiple myeloma. Blood 132(1):59\u201366","journal-title":"Blood"},{"issue":"6","key":"529_CR17","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1080\/10428194.2016.1233540","volume":"58","author":"E Muchtar","year":"2017","unstructured":"Muchtar E, Magen H, Gertz MA (2017) High-risk multiple myeloma: a\u00a0multifaceted entity, multiple therapeutic challenges. Leuk Lymphoma 58(6):1283\u20131296","journal-title":"Leuk Lymphoma"},{"key":"529_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0196-8","author":"BA Walker","year":"2018","unstructured":"Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F et al (2018) A high-risk, double-hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia. \n                    https:\/\/doi.org\/10.1038\/s41375-018-0196-8","journal-title":"Leukemia"},{"issue":"13","key":"529_CR19","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1182\/blood-2016-06-723007","volume":"128","author":"N Weinhold","year":"2016","unstructured":"Weinhold N, Ashby C, Rasche L, Chavan SS, Stein C, Stephens OW et al (2016) Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma. Blood 128(13):1735\u20131744","journal-title":"Blood"},{"issue":"20","key":"529_CR20","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1182\/blood-2014-07-552059","volume":"124","author":"B Barlogie","year":"2014","unstructured":"Barlogie B, Mitchell A, van Rhee F, Epstein J, Morgan GJ, Crowley J (2014) Curing myeloma at last: defining criteria and providing the evidence. Blood 124(20):3043\u20133051","journal-title":"Blood"},{"issue":"6","key":"529_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G et\u00a0al (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24(6):1121\u20131127","journal-title":"Leukemia"},{"key":"529_CR22","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00108-013-3336-2","volume":"54","author":"K Kort\u00fcm","year":"2013","unstructured":"Kort\u00fcm K, Engelhardt M, Rasche L et\u00a0al (2013) Das multiple Myelom. Internist 54:963\u2013977","journal-title":"Internist"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0529-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:20:49Z","timestamp":1575937249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0529-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0529-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"assertion":[{"value":"10 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Rasche und N.\u00a0Weinhold geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}